ClinicalTrials.Veeva

Menu

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

U

University of Milan

Status

Enrolling

Conditions

Extracellular Vesicles; Generation and Function
Lymphangioleiomyomatosis (LAM)

Treatments

Diagnostic Test: Pulmonary Function Test
Diagnostic Test: Analysis of Extracellular Vesicles

Study type

Observational

Funder types

Other

Identifiers

NCT07304856
LAM_EVs

Details and patient eligibility

About

Lymphangioleiomyomatosis (LAM) is a rare lung disease, linked to Tuberous Sclerosis Complex (TSC) or occurring sporadically, and involves abnormal mTORC1 activation. LAM cells are neoplastic, and recent focus has turned to extracellular vesicles (EVs), which mediate tumor progression and may serve as biomarkers. This study, conducted at the Pulmonology Unit of ASST Santi Paolo e Carlo and the Pharmacology Laboratory of the University of Milan, will analyze the characteristics of serum EVs in patients with LAM and TSC. During scheduled outpatient visits, clinical and functional data and blood samples will be collected. Plasma will be separated, and EVs will be isolated via centrifugation. EVs will be analyzed for size, concentration, and molecular content (proteins, lipids, nucleic acids). The results obtained will be collected and correlated with the clinical and functional data.

Enrollment

80 estimated patients

Sex

Female

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Female participants aged ≥18 years Confirmed diagnosis of tuberous sclerosis complex (TSC) and/or lymphangioleiomyomatosis (definite diagnosis of TSC-LAM or S-LAM) Follow-up at the Pulmonology Unit of ASST Santi Paolo e Carlo, Milan Ability to provide written informed consent

Exclusion criteria

Diagnosis of "probable" or "possible" LAM Refusal to provide written informed consent

Trial design

80 participants in 4 patient groups

S-LAM
Description:
Patients with sporadic LAM
Treatment:
Diagnostic Test: Analysis of Extracellular Vesicles
Diagnostic Test: Pulmonary Function Test
TSC-LAM
Description:
Patients with TSC-associated LAM
Treatment:
Diagnostic Test: Analysis of Extracellular Vesicles
Diagnostic Test: Pulmonary Function Test
TSC
Description:
Patients with TSC and no pulmonary involvement
Treatment:
Diagnostic Test: Analysis of Extracellular Vesicles
Diagnostic Test: Pulmonary Function Test
Control
Description:
Healthy subjects
Treatment:
Diagnostic Test: Analysis of Extracellular Vesicles
Diagnostic Test: Pulmonary Function Test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems